Skip to main content

JPMORGAN CHASE & CO

Position in SNDX — Syndax Pharmaceuticals Inc

CIK 19617 NEW YORK, NY

Position in SNDX

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$5,059,406
-$979,595 QoQ
Shares Held
231,446
-10.5% QoQ
Ownership
0.259%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#70
of 242 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 67% Shared 0% None 33%

Common Shares in SNDX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JPMORGAN CHASE & CO holds $12,920,143,201 across 425 Biotechnology names. SNDX ranks #115 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in SNDX

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,059,406 231,446
2026-03-31 $6,039,001 258,519
2025-12-31 $7,952,366 378,504
2025-09-30 $3,905,480 253,850
2025-06-30 $2,555,464 272,874
2025-03-31 $13,584,837 1,105,807
2024-12-31 $11,862,527 897,317
2024-09-30 $12,082,819 627,679
2024-06-30 $12,931,433 629,880
2024-03-31 $16,242,641 682,464
2023-12-31 $16,875,895 780,930
2023-09-30 $10,586,502 729,098
2023-06-30 $16,131,189 770,721
2023-03-31 $11,596,674 549,085
2022-12-31 $13,695,305 538,126
2022-09-30 $14,808,510 616,251
2022-06-30 $11,434,369 594,302
2022-03-31 $4,168,226 239,829
2021-12-31 $3,731,653 170,473
2021-09-30 $1,432,905 74,982
2021-06-30 $335,654 19,549
2021-03-31 $262,014 11,718
2020-12-31 $722,376 32,481
2020-09-30 $148,219 10,042
2020-06-30 $135,098 9,116
2020-03-31 $672,010 61,259